Table 1. Baseline characteristics by treatment group.
| Variable | Treatment group | ||
|---|---|---|---|
| Control | Positive framing | Negative framing | |
| Age of child (months) | 10.20 (0.48) | 10.56 (0.50) | 10.06 (0.51) |
| Child vaccines | |||
| DPT1 | 165/239 (69%) | 152/237 (64%) | 153/246 (62%) |
| DPT2 | 111/239 (46%) | 91/237 (38%) | 97/246 (39%) |
| DPT3 | 0/239 (0%) | 0/237 (0%) | 0/246 (0%) |
| BCG vaccine | 210/239 (88%) | 195/237 (82%) | 204/246 (83%) |
| Measles vaccine | 40/239 (17%) | 39/237 (16%) | 37/246 (15%) |
| Mother knows a cause of tetanus | 111/239 (46%) | 95/237 (40%) | 105/246 (43%) |
| Mother knows a symptom of tetanus | 20/239 (8%) | 17/237 (7%) | 24/246 (10%) |
| Mother knows a prevention method of tetanus | 100/239 (42%) | 95/237 (40%) | 99/246 (40%) |
| Perception of tetanus vaccination efficacy (index) | 7.38 (0.12) | 7.15 (0.13) | 7.23 (0.13) |
| Closest health facility to household | |||
| Government anganwadi centre | 137/239 (57%) | 153/237 (65%) | 156/246 (63%) |
| Government subcentre | 24/239 (10%) | 20/237 (8%) | 33/246 (13%) |
| Government clinic | 24/239 (10%) | 18/237 (8%) | 20/246 (8%) |
| Government other | 20/239 (8%) | 12/237 (5%) | 8/246 (3%) |
| Private clinic | 12/239 (5%) | 10/237 (4%) | 7/246 (3%) |
Values are n/N (%) for binary outcomes and mean (standard deviation) for continuous outcomes.
BCG, Bacillus Calmette–Guérin; DPT1, 1 dose of diphtheria–pertussis–tetanus vaccine; DPT2, 2 doses of diphtheria–pertussis–tetanus vaccine; DPT3, 3 doses of diphtheria–pertussis–tetanus vaccine.